Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3
Dominique Desplancq, Andrew Mountain(UCB Pharma (United Kingdom)), Alastair D. G. Lawson(UCB Pharma (United Kingdom)), David J. King(Regulus Therapeutics (United States))
Cited by 122
Related Papers
High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker
|Nature Biotechnology|1992|465
A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody
|Molecular Immunology|1993|243
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
|PubMed|1996|212
Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer
|Nature Communications|2019|128